Envoy Medical (COCH) Operating Leases (2022 - 2026)

Envoy Medical (COCH) reported Operating Leases of $711000.0 for Q1 2026, down 8.61% on a YoY basis from $778000.0 in Q1 2025, and down 4.56% sequentially from $745000.0 in Q4 2025.

Envoy Medical (COCH) Operating Leases (2022 - 2026) Analysis & Trends

Envoy Medical (COCH) has 5 years of Operating Leases data on file, last reported at $711000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 8.61% year-over-year to $711000.0; the trailing twelve-month figure through Mar 2026 stood at $711000.0 (down 8.61% YoY), and the FY2025 full-year result was $745000.0, down 7.11% from the prior year.
  • Operating Leases fell to $711000.0 in Q1 2026, from $745000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.1 million in Q2 2024 to a low of $378000.0 in Q1 2024.
  • A 5-year average of $730833.3 and a median of $728000.0 in 2025 frame the typical range for Operating Leases.
  • Peak annual rise in Operating Leases reached 105.82% in 2025, while the deepest fall reached 37.29% in 2025.
  • Tracing COCH's Operating Leases over 5 years: stood at $565000.0 in 2022, then dropped by 28.5% to $404000.0 in 2023, then surged by 98.51% to $802000.0 in 2024, then decreased by 7.11% to $745000.0 in 2025, then retreated by 4.56% to $711000.0 in 2026.
  • Business Quant data shows COCH's Operating Leases at $711000.0 in Q1 2026, $745000.0 in Q4 2025, and $946000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Envoy Medical 45.50 Mn 20.25 Mn -274,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 711,000.00
Dec 31, 2025 745,000.00
Sep 30, 2025 946,000.00
Jun 30, 2025 703,000.00
Mar 31, 2025 778,000.00
Dec 31, 2024 802,000.00
Sep 30, 2024 1.03 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 378,000.00
Dec 31, 2023 404,000.00
Sep 30, 2023 589,000.00
Dec 31, 2022 565,000.00